Sort by
Refine Your Search
-
wide-ranging expertise and interests. Karolinska Institutet is one of the world’s leading medical universities. Our vision is to pursue the development of knowledge about life and to promote a better
-
molecular biology, evolution and biodiversity, precision medicine and diagnostics, epidemiology and biology of infection. For more information, please see www.scilifelab.se/data-driven. During 2022-2024
-
member states to advance AI solutions, training, business and workforce development. Please read more: www.naiss.se , https://eurohpc ju.europa.eu/ai-factories_en . Main responsibilities As an application
-
within the development and evaluation of new materials in interaction with biological systems to understand the underlying principles. For us, it is equally important to study the impact of materials
-
at SciLifeLab, which provides national access to advanced imaging, training, and technology development. The Gothenburg node (IMT-GU) brings together the Centre for Cellular Imaging at the Sahlgrenska Academy
-
medicines and a healthier world. With laboratories in the heart of Uppsala Biomedical Center and Sweden’s only Faculty of Pharmacy, we are a vital engine in the development of education and research in
-
eager to contribute to the future of life science research. You stay up to date with the latest trends in AI and software development, and you thrive in an environment where new solutions are rapidly put
-
. omics), imaging, electronic health care records, longitudinal patient and population registries and biobanks. The applicant is expected to have a strong computational focus on innovative development and
-
academic collaboration between multiple Swedish universities and distributed national research infrastructure with a distinct focus on health and environmental research (http://www.scilifelab.se ). The core
-
, evolution and biodiversity, precision medicine and diagnostics, epidemiology and biology of infection. For more information, please see www.scilifelab.se/data-driven . During 2022-2024, the first and second